
Janice C. Hallmark
Examiner (ID: 18843)
| Most Active Art Unit | 2918 |
| Art Unit(s) | 2973, 2925, 2915, 2918 |
| Total Applications | 1734 |
| Issued Applications | 1710 |
| Pending Applications | 4 |
| Abandoned Applications | 27 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18281905
[patent_doc_number] => 20230097377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Biodegradable Implant Including Naltrexone
[patent_app_type] => utility
[patent_app_number] => 17/711910
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711910 | Biodegradable implant including naltrexone | Mar 31, 2022 | Issued |
Array
(
[id] => 17836295
[patent_doc_number] => 20220273600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/699892
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699892
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699892 | LITHIUM SALTS OF N-SUBSTITUTED GLYCINE COMPOUNDS AND USES THEREOF | Mar 20, 2022 | Abandoned |
Array
(
[id] => 19140519
[patent_doc_number] => 20240139310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/279459
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/279459 | MICROPARTICLE COMPOSITIONS AND METHODS USE THEREOF | Mar 8, 2022 | Pending |
Array
(
[id] => 19140332
[patent_doc_number] => 20240139108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE
[patent_app_type] => utility
[patent_app_number] => 18/547260
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547260
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547260 | ORAL PHARMACEUTICAL COMPOSITION OF ARSENIC TRIOXIDE | Feb 24, 2022 | Pending |
Array
(
[id] => 19691229
[patent_doc_number] => 20250009774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM
[patent_app_type] => utility
[patent_app_number] => 18/547934
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18547934
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/547934 | COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND MAGNESIUM | Feb 22, 2022 | Pending |
Array
(
[id] => 17640694
[patent_doc_number] => 20220168432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/675842
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675842 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17836363
[patent_doc_number] => 20220273668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => IRAK4 DEGRADERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/651201
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651201 | IRAK4 degraders and uses thereof | Feb 14, 2022 | Issued |
Array
(
[id] => 17895345
[patent_doc_number] => 20220305007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => INJECTABLE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/650822
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650822 | INJECTABLE FORMULATION | Feb 10, 2022 | Abandoned |
Array
(
[id] => 18351014
[patent_doc_number] => 20230139125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 17/912371
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912371
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912371 | DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE | Feb 2, 2022 | Abandoned |
Array
(
[id] => 17609816
[patent_doc_number] => 20220152095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => ELECTROLYTE COMPOSITION AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/587463
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/587463 | ELECTROLYTE COMPOSITION AND METHODS OF USE | Jan 27, 2022 | Pending |
Array
(
[id] => 19372955
[patent_doc_number] => 12064494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Methods, compositions, and delivery systems for therapeutic skin treatments
[patent_app_type] => utility
[patent_app_number] => 17/586214
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17586214
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/586214 | Methods, compositions, and delivery systems for therapeutic skin treatments | Jan 26, 2022 | Issued |
Array
(
[id] => 17733319
[patent_doc_number] => 20220218778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITION FOR REDUCING BODY FAT COMPRISING GREEN TEA EXTRACT CONTAINING GALLOCATECHIN GALLATE AS AN ACTIVE INGREDIENT AND MANUFACTURING METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/570765
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12391
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570765 | Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof | Jan 6, 2022 | Issued |
Array
(
[id] => 18970285
[patent_doc_number] => 20240050377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/260276
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/260276 | ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Dec 22, 2021 | Pending |
Array
(
[id] => 19001986
[patent_doc_number] => 20240066057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/258518
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11734
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258518
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258518 | METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS | Dec 19, 2021 | Pending |
Array
(
[id] => 18762874
[patent_doc_number] => 11813253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Composition and method for proton pump inhibitor suspension
[patent_app_type] => utility
[patent_app_number] => 17/554737
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9316
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554737 | Composition and method for proton pump inhibitor suspension | Dec 16, 2021 | Issued |
Array
(
[id] => 18503562
[patent_doc_number] => 11701352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Process for preparing aripiprazole oral soluble film
[patent_app_type] => utility
[patent_app_number] => 17/552333
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5788
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552333 | Process for preparing aripiprazole oral soluble film | Dec 14, 2021 | Issued |
Array
(
[id] => 17702721
[patent_doc_number] => 20220202727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => HYDROGEL COMPOSITIONS COMPRISING ENCAPSULATED CELLS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/546489
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546489
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546489 | HYDROGEL COMPOSITIONS COMPRISING ENCAPSULATED CELLS AND METHODS OF USE THEREOF | Dec 8, 2021 | Abandoned |
Array
(
[id] => 17625624
[patent_doc_number] => 20220160639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
[patent_app_type] => utility
[patent_app_number] => 17/538333
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17538333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/538333 | MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) | Nov 29, 2021 | Abandoned |
Array
(
[id] => 18163506
[patent_doc_number] => 20230030099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING MARMELO EXTRACT FOR PREVENTING OR TREATING OBESITY
[patent_app_type] => utility
[patent_app_number] => 17/535815
[patent_app_country] => US
[patent_app_date] => 2021-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17535815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/535815 | PHARMACEUTICAL COMPOSITION COMPRISING MARMELO EXTRACT FOR PREVENTING OR TREATING OBESITY | Nov 25, 2021 | Abandoned |
Array
(
[id] => 17625613
[patent_doc_number] => 20220160628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PROCESS FOR MANUFACTURING IMPROVED SEMI-SOFT SOLID DOSAGE FORMS AND SOFT CHEWS PRODUCED THEREBY
[patent_app_type] => utility
[patent_app_number] => 17/534947
[patent_app_country] => US
[patent_app_date] => 2021-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534947 | PROCESS FOR MANUFACTURING IMPROVED SEMI-SOFT SOLID DOSAGE FORMS AND SOFT CHEWS PRODUCED THEREBY | Nov 23, 2021 | Pending |